Advocacy Tools
Advocacy materials and tools developed by hepCoalition and partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Includes training materials, community monitoring/data collection, and graphics.
Materials in this section
Essential Harm Reduction Services in Europe: Report on Policy Implementation for People Who Use Drugs
C-EHRN releases a report assessing the state of essential harm reduction services in 40 European cities in 2024. More
Global State of Harm Reduction 2024
Harm Reduction International releases the 9th edition of the Global State of Harm Reduction report, providing an independent analysis of harm reduction in the world. More
INHSU Prisons Hepatitis C Advocacy Toolkit
The toolkit provides guidance across three core areas with the aim of supporting advocacy efforts for the scale-up or implementation of prison-based hepatitis C testing, treatment and prevention services. More
Hidden Costs: GeneXpert Tests and Danaher’s Delayed Audit
A technical brief makes recommendations to Danaher, as well as global health actors and governments, to ensure the audit is conducted in a timely, rigorous and transparent manner. More
Creating Safer Consumption Spaces in Europe: Evolving Contexts and Implications for Policy
C-EHRN releases a policy brief providing an overview of the state of the art regarding Drug Consumption Rooms, as well as an overview of recommendations and examples of good practices for policymakers. More
The Cost of Complacency: A Harm Reduction Funding Crisis
Harm Reduction International releases its annual report exploring the state of harm reduction funding in low- and middle-income countries. More
HIV and Viral Hepatitis Diagnostic Tests in LMICs: Forecasts of Global and Regional Demand for 2022-2026
WHO releases a report jointly presenting diagnostic test forecasts across disease areas in recognition of the benefits of addressing HIV and viral hepatitis B and C in a coordinated manner. More
Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030: WHO Report on Progress and Gaps 2024
New WHO report flags major increase in sexually transmitted infections, amidst challenges in HIV and hepatitis. More
Medicines for HIV, Viral Hepatitis, and STIs in LMICs: Forecasts of Global Demand for 2022-2026
WHO releases a report jointly presenting medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner. More
2024 Global Hepatitis Report
WHO sounds alarm on viral hepatitis infections claiming 3500 lives each day. Viral hepatitis is the second leading infectious cause of death globally. More
